Delayed intracardial shunting and hypoxemia after massive pulmonary embolism in a patient with a biventricular assist device
© Weig et al; licensee BioMed Central Ltd. 2011
Received: 19 August 2011
Accepted: 11 October 2011
Published: 11 October 2011
We describe the interdisciplinary management of a 34-year-old woman with dilated cardiomyopathy three months postpartum on a cardiac biventricular assist device (BVAD) as bridge to heart transplantation with delayed onset of intracardial shunting and subsequent hypoxemia due to massive pulmonary embolism. After emergency surgical embolectomy pulmonary function was highly compromised (PaO2/FiO2 54) requiring bifemoral veno-venous extracorporeal membrane oxygenation. Transesophageal echocardiography detected atrial level hypoxemic right-to-left shunting through a patent foramen ovale (PFO). Percutaneous closure of the PFO was achieved with a PFO occluder device. After placing the PFO occluder device oxygenation increased significantly (Δ paO2 119 Torr). The patient received heart transplantation 20 weeks after BVAD implantation and was discharged from ICU 3 weeks after transplantation.
An increase in pulmonary vascular resistance in patients on BVAD can reopen a PFO resulting in atrial right-to-left shunting and subsequent hypoxemia. The case demonstrates the usefulness of transesophageal echocardiography examinations in the detection of this unexpected event. Percutaneous placement of a PFO occluder device is an appropriate strategy to stop intracardiac shunting through PFO in fixed elevation of pulmonary vascular resistance.
Keywordspatent foramen ovale hypoxemia pulmonary embolism ventricle-assist device heart transplantation septal occluder device
In a literature review, few cases of atrial level right-to-left shunt in patients with left ventricular assist devices are described. All these cases were detected either intraoperatively [1–3] or within the first postoperative days [4–7]. We describe a case of delayed onset of atrial level right-to-left shunt after massive pulmonary embolism on biventricular assist device (BVAD) support.
A 34 year old female patient was admitted to our hospital with dilated cardiomyopathy three months after birth of her third child. She had a known history of familial dilated cardiomyopathy. Recompensation was not achieved despite maximum medical therapy and insertion of an intra-aortic balloon pump. BVAD [Excor, Berlin Heart, Berlin, Germany] was implanted using a bi-atrial cannulation technique as bridge to heart transplantation. Perioperative transesophageal echocardiography did not show a patent foramen ovale (PFO). Postoperative recovery was immediate and the patient was discharged from the ICU on the third postoperative day.
Additional file 1: Transesophageal echocardiogram. Transesophageal echocardiogram before and after patent foramen ovale closure with a PFO occluder device [Amplatzer PFO Occluder®, AGA Medical, Plymouth, USA]. (MOV 2 MB)
After 5 weeks of therapeutic anticoagulation the residual emboli diminished and pulmonary vascular resistance was measured at 184 dyne•s/cm5 with activated assist device and 160 dyne•s/cm5 with deactivated assist device.
Heart transplantation was performed 20 weeks after implantation of the BVAD and 16 weeks after pulmonary embolism and placement of the PFO occluder device. Discharge from ICU was 3 weeks after transplantation. Informed consent for publication was obtained from the patient.
The problem with PFO and left ventricular assist device leading to atrial level right-to-left shunt with consecutive hypoxemia is well described [1–7]. PFO has an incidence up to 27% in normal healthy adults as well as in adult cardiac surgical patients [8, 9]. If left ventricular assist device (LVAD) is activated, left atrial unloading leads to a decrease in left atrial pressure . Right atrial pressure exceeds left atrial pressure and with PFO atrial level right-to-left shunt occurs. Depending on the shunt fraction hypoxemia may occur .
Therefore, intraoperative transesophageal echocardiography with colour Doppler imaging and contrast with agitated saline is highly recommended before cardiopulmonary bypass and after LVAD activation [12, 13]. Alternatively, manual occlusion of the pulmonary artery shortly before activation of the LVAD by the surgeon and transesophageal echocardiography studies as described are performed . If PFO is detected before weaning from cardiopulmonary bypass, immediate operative closure is recommended. If shunting is detected after weaning from cardiopulmonary bypass, delayed interventional closure after stabilization is preferred if oxygenation failure is tolerable, since failure of the right heart in LVAD implantation or bleeding complications due to coagulopathy after reapplied bypass can deteriorate outcome . PFO closure improved oxygenation in all known cases as it did in our patient.
There is only one other case of delayed onset of atrial level right-to-left shunt in patients on ventricular assist device . In this case report, atrial level right-to-left shunt with hypoxemia occurred after replacement of the valves of a LVAD [LVAS, Novacor, Salt Lake City, USA] which had been implanted one year before. The management consisted of reduction of right atrial pressure by conservative means.
Persisting elevation of right atrial pressure due to persisting change of the pulmonary vascular resistance in a patient with a BVAD has not been described. An etiologic reason for persisting elevation of pulmonary vascular resistance can be massive pulmonary embolism as described in our case. Our report is the first description of a patient surviving massive pulmonary embolism while on BVAD, followed by successful orthotopic heart transplantation. To the best of our knowledge there is only one other published case of pulmonary embolism in a patient with a BVAD. This patient died shortly after the event .
Emergency surgical embolectomy is recommended in hemodynamic unstable patients with massive pulmonary embolism in a facility with cardiac surgical capabilities . Catheter embolectomy should be performed in absence of cardiothoracic surgical backup . In our case, thrombolysis was contraindicated. Therefore emergency surgical embolectomy was the treatment of choice. The reported median reduction of pulmonary vascular resistance achieved by surgical embolectomy is from 893 ± 443.5 dyne•s/cm5 to 285 ± 214 dyne•s/cm5, a result that was achieved in our patient.
With regard to the planned heart transplantation, chronic thromboembolic pulmonary hypertension would have been an exclusion criterion.
Diagnostic transesophageal echocardiography must be performed with relevant change in the hemodynamic situation and recurring hypoxemia in patients with VAD since increase in pulmonary vascular resistance can reopen PFO resulting in atrial level right-to-left shunting and consecutive hypoxemia.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Baker JE, Stratmann G, Hoopes C, Donateillo R, Tseng E, Russell IA: Profound hypoxemia resulting from shunting across an inadvertent atrial septal tear after left ventricular assist device placement. Anesth Analg. 2004, 98 (4): 937-940.View ArticlePubMedGoogle Scholar
- Kavarana MN, Rahman FA, Recto MR, Dowling RD: Transcatheter closure of patent foramen ovale after left ventricular assist device implantation: intraoperative decision making. J Heart Lung Transplant. 2005, 24 (9): 1445-View ArticlePubMedGoogle Scholar
- Nguyen DQ, Das GS, Grubbs BC, Bolman RM, Park SJ: Transcatheter closure of patent foramen ovale for hypoxemia during left ventricular assist device support. J Heart Lung Transplant. 1999, 18 (10): 1021-1023. 10.1016/S1053-2498(99)00064-9.View ArticlePubMedGoogle Scholar
- Bonvini RF, Verin V, Lerch R, Gerard I, Sierra J, Spratt JC: Percutaneous closure of patent foramen ovale in a patient presenting arterial hypoxaemia and supported with bi-ventricular assist device. Intensive Care Med. 2005, 31 (4): 602-603. 10.1007/s00134-004-2466-3.View ArticlePubMedGoogle Scholar
- Loeffelbein F, Schlensak C, Beyersdorf F, Dittrich S: Successful interventional closure of a patent foramen ovale in a pediatric patient supported with a biventricular assist device. Interact Cardiovasc Thorac Surg. 2007, 6 (6): 778-779. 10.1510/icvts.2007.155622.View ArticlePubMedGoogle Scholar
- Loyalka P, Idelchik GM, Kar B: Percutaneous left ventricular assist device complicated by a patent foramen ovale: importance of identification and management. Catheter Cardiovasc Interv. 2007, 70 (3): 383-386. 10.1002/ccd.21185.View ArticlePubMedGoogle Scholar
- Srinivas CV, Collins N, Borger MA, Horlick E, Murphy PM: Hypoxemia complicating LVAD insertion: novel application of the Amplatzer PFO occlusion device. J Card Surg. 2007, 22 (2): 156-158. 10.1111/j.1540-8191.2007.00370.x.View ArticlePubMedGoogle Scholar
- Augoustides JG, Weiss SJ, Weiner J, Mancini J, Savino JS, Cheung AT: Diagnosis of patent foramen ovale with multiplane transesophageal echocardiography in adult cardiac surgical patients. J Cardiothorac Vasc Anesth. 2004, 18 (6): 725-730. 10.1053/j.jvca.2004.08.009.View ArticlePubMedGoogle Scholar
- Hagen PT, Scholz DG, Edwards WD: Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984, 59 (1): 17-20.View ArticlePubMedGoogle Scholar
- Nakatani S, Thomas JD, Savage RM, Vargo RL, Smedira NG, McCarthy PM: Prediction of right ventricular dysfunction after left ventricular assist device implantation. Circulation. 1996, 94 (9 Suppl): II216-221.PubMedGoogle Scholar
- Godart F, Rey C, Prat A, Vincentelli A, Chmait A, Francart C, Porte H: Atrial right-to-left shunting causing severe hypoxaemia despite normal right-sided pressures - Report of 11 consecutive cases corrected by percutaneous closure. Eur Heart J. 2000, 21 (6): 483-489. 10.1053/euhj.1999.1944.View ArticlePubMedGoogle Scholar
- Chumnanvej S, Wood MJ, MacGillivray TE, Melo MF: Perioperative echocardiographic examination for ventricular assist device implantation. Anesth Analg. 2007, 105 (3): 583-601. 10.1213/01.ane.0000278088.22952.82.View ArticlePubMedGoogle Scholar
- Liao KK, Miller L, Toher C, Ormaza S, Herrington CS, Bittner HB, Park SJ: Timing of transesophageal echocardiography in diagnosing patent foramen ovale in patients supported with left ventricular assist device. Ann Thorac Surg. 2003, 75 (5): 1624-1626. 10.1016/S0003-4975(02)04676-3.View ArticlePubMedGoogle Scholar
- Majd RE, Kavarana MN, Bouvette M, Dowling RD: Improved technique to diagnose a patent foramen ovale during left ventricular assist device insertion. Ann Thorac Surg. 2006, 82 (5): 1917-1918. 10.1016/j.athoracsur.2005.09.030.View ArticlePubMedGoogle Scholar
- Kilger E, Strom C, Frey L, Felbinger TW, Pichler B, Tichy M, Rank N, Wheeldon D, Kesel K, Schmitz C: Intermittent atrial level right-to-left shunt with temporary hypoxemia in a patient during support with a left ventricular assist device. Acta Anaesthesiol Scand. 2000, 44 (1): 125-127. 10.1034/j.1399-6576.2000.440122.x.View ArticlePubMedGoogle Scholar
- Beitzke D, Wieselthaler G, Schima H, Loewe C: Pulmonary embolism in a patient with a biventricular assist device--imaging with multislice computed tomography. Eur J Cardiothorac Surg. 2011, 39 (3): 415.-10.1016/j.ejcts.2010.07.009.View ArticlePubMedGoogle Scholar
- Samoukovic G, Malas T, deVarennes B: The role of pulmonary embolectomy in the treatment of acute pulmonary embolism: a literature review from 1968 to 2008. Interact Cardiovasc Thorac Surg. 2010, 11 (3): 265-270. 10.1510/icvts.2009.228361.View ArticlePubMedGoogle Scholar
- Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, Channick RN, Fedullo PF, Auger WR: Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg. 2003, 76 (5): 1457-1462. 10.1016/S0003-4975(03)00828-2.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.